What lab work is recommended to diagnose and manage iron deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Iron Deficiency

The minimum initial laboratory workup for diagnosing iron deficiency should include a complete blood count (CBC), serum ferritin, transferrin saturation (TSAT), and C-reactive protein (CRP). 1, 2

Initial Screening Tests

Start with these core tests:

  • Complete Blood Count (CBC) with red cell indices including hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red cell distribution width (RDW) 1, 2
  • Serum ferritin as the primary marker of iron stores 1, 2
  • Transferrin saturation (TSAT) to assess iron immediately available for erythropoiesis 1, 2
  • C-reactive protein (CRP) to detect inflammation that may affect ferritin interpretation 1

Why These Tests Matter

Hemoglobin is preferred over hematocrit because it is more reproducible across laboratories and not affected by storage time or patient variables like serum glucose. 2 However, hemoglobin and hematocrit are late indicators of iron deficiency—they only become abnormal after iron stores are depleted and erythropoiesis is impaired. 2

RDW is particularly useful: an elevated RDW (>14.0%) combined with microcytosis strongly suggests iron deficiency anemia. 2 A high RDW can also help identify situations where microcytosis and macrocytosis coexist and neutralize each other, resulting in a falsely normal MCV. 1

Diagnostic Thresholds

Without Inflammation Present

  • Ferritin <30 ng/mL indicates iron deficiency 1, 2
  • Ferritin <15 ng/mL has 99% specificity for iron deficiency 2
  • Ferritin <45 ng/mL provides 92% specificity and is the recommended cutoff by the American Gastroenterological Association 1, 2
  • TSAT <20% confirms iron deficiency 1, 2

With Inflammation or Chronic Disease

This is a critical distinction: Ferritin is an acute-phase reactant and can be falsely elevated in the presence of inflammation, infection, chronic disease, hepatitis, cirrhosis, neoplasia, or arthritis. 2, 3

  • Ferritin <100 ng/mL should be used as the diagnostic threshold when inflammation is present 1, 2
  • TSAT <20% remains a reliable indicator as it is less affected by inflammation than ferritin 2, 3

For patients with inflammatory bowel disease specifically, if ferritin is between 30-100 ng/mL, this suggests a combination of true iron deficiency and anemia of chronic disease. 1

Additional Tests for Unclear Cases

When the diagnosis remains uncertain after initial testing, add:

  • Reticulocyte count to assess bone marrow response to anemia 1

    • Low or "normal" reticulocytes indicate inability to respond properly, suggesting deficiencies or bone marrow disease
    • Increased reticulocytes indicate increased red cell formation and exclude deficiencies; instead consider hemolysis 1
  • Vitamin B12 and folic acid if macrocytosis is present or suspected 1

  • Haptoglobin, lactate dehydrogenase, and bilirubin if hemolysis is suspected (elevated reticulocytes) 1

  • Soluble transferrin receptor (sTfR) reflects cellular iron deficits and is less affected by inflammation, though not routinely available at most hospitals 2

  • Reticulocyte hemoglobin content provides direct assessment of functional iron availability but requires specialized equipment 2

Monitoring Frequency

For Inflammatory Bowel Disease Patients

  • Every 6-12 months for patients in remission or with mild disease 1
  • Every 3 months for outpatients with active disease 1

After Starting Iron Supplementation

Do not check iron parameters within 4 weeks of receiving IV iron—circulating iron interferes with assays and gives falsely elevated results. 2

  • Recheck iron parameters at 4-8 weeks after starting supplementation to assess response 2
  • Hemoglobin should increase by 1-2 g/dL within 4-8 weeks if treatment is working 2

Common Pitfalls to Avoid

Do not rely solely on hemoglobin and hematocrit for diagnosis—these are late indicators that only become abnormal after iron stores are depleted. 2

Do not ignore inflammatory markers when interpreting ferritin levels. Chronic disease, infection, or inflammation can mask true iron deficiency by elevating ferritin independent of iron status. 2

Do not test iron parameters too soon after IV iron administration—wait at least 4 weeks to avoid spurious results. 2

In men and postmenopausal women with iron deficiency anemia, do not assume dietary insufficiency—approximately 62% have gastrointestinal bleeding from lesions requiring further investigation. 2 These patients require bidirectional endoscopy. 1

Recognize that serum iron has significant diurnal variation and increases after meals, making it less reliable as a standalone test. 2

Underlying Cause Investigation

Once iron deficiency is confirmed, test for underlying causes:

  • Non-invasive H. pylori testing (conditional recommendation for asymptomatic patients with iron deficiency anemia) 1
  • Celiac disease serologic testing (tissue transglutaminase antibodies) before proceeding to small bowel biopsy 1, 2
    • Check for IgA deficiency if TTG is negative but clinical suspicion remains, as IgA deficiency causes falsely negative TTG readings 2
  • Bidirectional endoscopy is strongly recommended for postmenopausal women and men with iron deficiency anemia 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laboratory Tests for Diagnosing Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.